These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23222298)

  • 41. Genome-wide TOP2A DNA cleavage is biased toward translocated and highly transcribed loci.
    Yu X; Davenport JW; Urtishak KA; Carillo ML; Gosai SJ; Kolaris CP; Byl JAW; Rappaport EF; Osheroff N; Gregory BD; Felix CA
    Genome Res; 2017 Jul; 27(7):1238-1249. PubMed ID: 28385713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chromatin regulators mediate anthracycline sensitivity in breast cancer.
    Seoane JA; Kirkland JG; Caswell-Jin JL; Crabtree GR; Curtis C
    Nat Med; 2019 Nov; 25(11):1721-1727. PubMed ID: 31700186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endogenous topoisomerase II-mediated DNA breaks drive thymic cancer predisposition linked to ATM deficiency.
    Álvarez-Quilón A; Terrón-Bautista J; Delgado-Sainz I; Serrano-Benítez A; Romero-Granados R; Martínez-García PM; Jimeno-González S; Bernal-Lozano C; Quintero C; García-Quintanilla L; Cortés-Ledesma F
    Nat Commun; 2020 Feb; 11(1):910. PubMed ID: 32060399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Abnormality of TOP2A expression and its gene copy number variations in neuroblastic tumors].
    Chen JM; Zhou CJ; Ma XL; Guan DD; Yang LY; Yue P; Gong LP
    Zhonghua Bing Li Xue Za Zhi; 2016 Nov; 45(11):748-754. PubMed ID: 27821228
    [No Abstract]   [Full Text] [Related]  

  • 45. Trapped topoisomerase II initiates formation of de novo duplications via the nonhomologous end-joining pathway in yeast.
    Stantial N; Rogojina A; Gilbertson M; Sun Y; Miles H; Shaltz S; Berger J; Nitiss KC; Jinks-Robertson S; Nitiss JL
    Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26876-26884. PubMed ID: 33046655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Etoposide-induced DNA damage is increased in p53 mutants: identification of ATR and other genes that influence effects of p53 mutations on Top2-induced cytotoxicity.
    Menendez D; Anand JR; Murphy CC; Bell WJ; Fu J; Slepushkina N; Buehler E; Martin SE; Lal-Nag M; Nitiss JL; Resnick MA
    Oncotarget; 2022; 13():332-346. PubMed ID: 35178190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcription-associated topoisomerase 2α (TOP2A) activity is a major effector of cytotoxicity induced by G-quadruplex ligands.
    Bossaert M; Pipier A; Riou JF; Noirot C; Nguyên LT; Serre RF; Bouchez O; Defrancq E; Calsou P; Britton S; Gomez D
    Elife; 2021 Jun; 10():. PubMed ID: 34180392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nuclear Transglutaminase 2 interacts with topoisomerase II⍺ to promote DNA damage repair in lung cancer cells.
    Lei X; Cao K; Chen Y; Shen H; Liu Z; Qin H; Cai J; Gao F; Yang Y
    J Exp Clin Cancer Res; 2021 Jul; 40(1):224. PubMed ID: 34225780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MDM2 provides TOP2 poison resistance by promoting proteolysis of TOP2βcc in a p53-independent manner.
    Shu J; Jiang J; Wang X; Yang X; Zhao G; Cai T
    Cell Death Dis; 2024 Jan; 15(1):83. PubMed ID: 38263255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ribosomal protein S11 influences glioma response to TOP2 poisons.
    Awah CU; Chen L; Bansal M; Mahajan A; Winter J; Lad M; Warnke L; Gonzalez-Buendia E; Park C; Zhang D; Feldstein E; Yu D; Zannikou M; Balyasnikova IV; Martuscello R; Konerman S; Győrffy B; Burdett KB; Scholtens DM; Stupp R; Ahmed A; Hsu P; Sonabend AM
    Oncogene; 2020 Jul; 39(27):5068-5081. PubMed ID: 32528131
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nucleolar translocation of human DNA topoisomerase II by ATP depletion and its disruption by the RNA polymerase I inhibitor BMH-21.
    Morotomi-Yano K; Yano KI
    Sci Rep; 2021 Nov; 11(1):21533. PubMed ID: 34728715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of eIF3a on anthracycline-based chemotherapy resistance by regulating DSB DNA repair.
    Chen J; Liu JY; Dong ZZ; Zou T; Wang Z; Shen Y; Zhuo W; Li XP; Xiao D; Liu HT; Chen X; Zhou HH; Liu ZQ; Zhang JT; Yin JY
    Biochem Pharmacol; 2021 Aug; 190():114616. PubMed ID: 34022189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cryptolepine Targets TOP2A and Inhibits Tumor Cell Proliferation in Breast Cancer Cells -
    Mehraj U; Qayoom H; Shafi S; Farhana P; Asdaq SMB; Mir MA
    Anticancer Agents Med Chem; 2022; 22(17):3025-3037. PubMed ID: 35440335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ATP-dependent chromatin remodelling enzyme Uls1 prevents Topoisomerase II poisoning.
    Swanston A; Zabrady K; Ferreira HC
    Nucleic Acids Res; 2019 Jul; 47(12):6172-6183. PubMed ID: 31106359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topoisomerase II contributes to DNA secondary structure-mediated double-stranded breaks.
    Szlachta K; Manukyan A; Raimer HM; Singh S; Salamon A; Guo W; Lobachev KS; Wang YH
    Nucleic Acids Res; 2020 Jul; 48(12):6654-6671. PubMed ID: 32501506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of Topoisomerase II (TOP2A) and Dual-Specificity Phosphatase 6 (DUSP6) Single Nucleotide Polymorphisms with Radiation Treatment Response and Prognosis of Lung Cancer in Han Chinese.
    Wang TL; Ren YW; Wang HT; Yu H; Zhao YX
    Med Sci Monit; 2017 Feb; 23():984-993. PubMed ID: 28231233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DNA topoisomerase 1 and 2A function as oncogenes in liver cancer and may be direct targets of nitidine chloride.
    Liu LM; Xiong DD; Lin P; Yang H; Dang YW; Chen G
    Int J Oncol; 2018 Nov; 53(5):1897-1912. PubMed ID: 30132517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RAD54L2 counters TOP2-DNA adducts to promote genome stability.
    D'Alessandro G; Morales-Juarez DA; Richards SL; Nitiss KC; Serrano-Benitez A; Wang J; Thomas JC; Gupta V; Voigt A; Belotserkovskaya R; Goh CG; Bowden AR; Galanty Y; Beli P; Nitiss JL; Zagnoli-Vieira G; Jackson SP
    Sci Adv; 2023 Dec; 9(49):eadl2108. PubMed ID: 38055822
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA Fragility.
    Atkin ND; Raimer HM; Wang YH
    Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31614754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
    Shu J; Wang X; Yang X; Zhao G
    Sci Rep; 2023 Jan; 13(1):882. PubMed ID: 36650267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.